Sladjana Prisic Selected Research

edaxadiene

8/2009

Characterization and inhibition of a class II diterpene cyclase from Mycobacterium tuberculosis: implications for tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sladjana Prisic Research Topics

Disease

5	Tuberculosis (Tuberculoses) 01/2018 - 08/2009
1	Infections 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2014
1	Fragile X Syndrome (Martin Bell Syndrome) 05/2014
1	Intellectual Disability (Idiocy) 05/2014
1	Genomic Instability 05/2014

Drug/Important Bio-Agent (IBA)

2	Phosphotransferases (Kinase)IBA 01/2018 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 10/2014 - 04/2010
1	MicronutrientsIBA 01/2021
1	CholesterolIBA 10/2014
1	CarbonIBA 10/2014
1	Fragile X Mental Retardation ProteinIBA 05/2014
1	ChromatinIBA 05/2014
1	edaxadieneIBA 08/2009
1	DiterpenesIBA 08/2009

Therapy/Procedure

1	Therapeutics 10/2014